Status | Study |
Completed |
Study Name: The Safety and Efficacy of Canakinumab in Patients Aged 4 Years or Older Diagnosed With Cryopyrin-associated Periodic Syndromes (CAPS) in Canada Condition: Cryopyrin Associated Periodic Syndrome Date: 2010-03-25 Interventions: Drug: canakinumab (company code: ACZ885D) |
Completed |
Study Name: Safety and Tolerability of Rilonacept in Muckle-Wells Syndrome (MWS) or Schnitzler Syndrome (SchS) Condition: Muckle-Wells Syndrome Schnitzler Syndrome Date: 2010-01-07 Interventions: Drug: rilonacept 160mg of rilonacept 1x/week Other N |
Completed |
Study Name: Efficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension Phase Condition: Cryopyrin-associated Periodic Syndromes Familial Cold Autoinfla Date: 2009-10-06 Interventions: Drug: canakinumab canakinumab |
Terminated |
Study Name: Canakinumab to Treat Neonatal-Onset Multisystem Inflammatory Disease Condition: NOMID CINCA Syndrome Date: 2008-10-09 Interventions: Drug: Canakinumab |
Completed |
Study Name: Efficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease Condition: Cryopyrin-Associated Periodic Syndromes Familial Cold Autoinfla Date: 2008-05-27 Interventions: Drug: Canakinumab (ACZ885) 6 mL glass vial containing 150 mg lyophilized Canakinumab reconstituted with |
Completed |
Study Name: Efficacy, Safety, and Tolerability of ACZ885 in Patients With Muckle-Wells Syndrome Condition: Muckle Wells Syndrome Date: 2007-04-25 Interventions: Drug: ACZ885 Drug: Placebo |
Completed |
Study Name: Rilonacept for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS) Condition: Familial Cold Autoinflammatory Syndrome (FCAS) Familial Cold Urticaria Date: 2006-02-06 Interventions: Drug: rilonacept 160 mg Rilona |
Completed |
Study Name: The Use of Kineret (Anakinra) in the Treatment of Familial Cold Urticaria Condition: Familial Cold Urticaria Date: 2005-09-21 Interventions: Drug: Kineret (anakinra) Kineret (anakinra 100 mg. s/c daily x 4 weeks |
Terminated |
Study Name: Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease Condition: Nervous System Malformations Arthropathy, Neurogenic Urtic Date: 2003-09-22 Interventions: Drug: anakinra daily injection of subcutaneous injection |